ICU MEDICAL INC/DE - Common Stock (ICUI)

CUSIP: 44930G107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock
Shares outstanding
24,701,460
Total 13F shares
20,303,486
Share change
+244,805
Total reported value
$4,177,920,660
Put/Call ratio
32%
Price per share
$205.80
Number of holders
266
Value change
+$50,461,509
Number of buys
112
Number of sells
126

Quarterly Holders Quick Answers

What is CUSIP 44930G107?
CUSIP 44930G107 identifies ICUI - ICU MEDICAL INC/DE - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ICUI - ICU MEDICAL INC/DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
10%
2,577,820
$529,587,000 31 Mar 2021
13F
JANUS HENDERSON GROUP PLC
13F
Company
9.8%
2,425,882
$498,373,000 31 Mar 2021
13F
VANGUARD GROUP INC
13F
Company
7.5%
1,846,215
$379,286,000 31 Mar 2021
13F
BlackRock Finance, Inc.
13F
Company
7.1%
1,743,308
$358,145,000 31 Mar 2021
13F
NUANCE INVESTMENTS, LLC
13F
Company
4.2%
1,035,101
$212,651,000 31 Mar 2021
13F
JPMORGAN CHASE & CO
13F
Company
3.7%
909,136
$186,774,000 31 Mar 2021
13F
Findlay Park Partners LLP
13F
Company
2.7%
671,136
$137,878,000 31 Mar 2021
13F
STATE STREET CORP
13F
Company
2.1%
511,716
$105,127,000 31 Mar 2021
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
1.8%
443,513
$91,115,000 31 Mar 2021
13F
ATLANTA CAPITAL MANAGEMENT CO L L C
13F
Company
1.5%
359,269
$73,808,000 31 Mar 2021
13F
SILVERCREST ASSET MANAGEMENT GROUP LLC
13F
Company
1.4%
334,103
$68,638,000 31 Mar 2021
13F
Neuberger Berman Group LLC
13F
Company
1.2%
292,513
$60,086,000 31 Mar 2021
13F
PFM Health Sciences, LP
13F
Company
1.2%
290,661
$59,713,000 31 Mar 2021
13F
EATON VANCE MANAGEMENT
13F
Company
1.2%
289,715
$59,519,000 31 Mar 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.1%
266,197
$54,579,000 31 Mar 2021
13F
Nitorum Capital, L.P.
13F
Company
1%
252,668
$51,908,000 31 Mar 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1%
252,487
$51,870,000 31 Mar 2021
13F
Redmile Group, LLC
13F
Company
0.91%
224,154
$46,050,000 31 Mar 2021
13F
NORTHERN TRUST CORP
13F
Company
0.89%
218,969
$44,987,000 31 Mar 2021
13F
Invesco Ltd.
13F
Company
0.84%
208,465
$42,829,000 31 Mar 2021
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.84%
206,862
$42,498,000 31 Mar 2021
13F
Bank of New York Mellon Corp
13F
Company
0.79%
195,099
$40,081,000 31 Mar 2021
13F
Point72 Asset Management, L.P.
13F
Company
0.74%
182,610
$37,515,000 31 Mar 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.74%
182,364
$37,465,000 31 Mar 2021
13F
NORGES BANK
13F
Company
0.69%
171,471
$35,227,000 31 Mar 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.62%
152,187
$31,266,000 31 Mar 2021
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.6%
148,548
$30,518,000 31 Mar 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.58%
144,026
$29,589,000 31 Mar 2021
13F
Boston Trust Walden Corp
13F
Company
0.58%
142,666
$29,309,000 31 Mar 2021
13F
SEGALL BRYANT & HAMILL, LLC
13F
Company
0.55%
135,746
$27,886,000 31 Mar 2021
13F
GW&K Investment Management, LLC
13F
Company
0.5%
124,633
$25,605,000 31 Mar 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.5%
122,862
$25,241,000 31 Mar 2021
13F
FEDERATED HERMES, INC.
13F
Company
0.48%
118,203
$24,283,000 31 Mar 2021
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.39%
95,576
$19,629,000 31 Mar 2021
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.37%
92,370
$18,976,000 31 Mar 2021
13F
GLENMEDE TRUST CO NA
13F
Company
0.33%
81,887
$16,821,000 31 Mar 2021
13F
TD ASSET MANAGEMENT INC
13F
Company
0.33%
81,045
$16,650,000 31 Mar 2021
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
0.32%
78,573
$16,299,000 31 Mar 2021
13F
Woodline Partners LP
13F
Company
0.32%
78,475
$16,122,000 31 Mar 2021
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.31%
75,804
$15,573,000 31 Mar 2021
13F
DEUTSCHE BANK AG\
13F
Company
0.29%
72,034
$14,799,000 31 Mar 2021
13F
Tamarack Advisers, LP
13F
Company
0.28%
70,000
$14,381,000 31 Mar 2021
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.27%
67,841
$13,937,000 31 Mar 2021
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.27%
66,284
$13,617,000 31 Mar 2021
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.26%
63,228
$12,990,000 31 Mar 2021
13F
FIRST TRUST ADVISORS LP
13F
Company
0.23%
57,123
$11,736,000 31 Mar 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.22%
55,505
$11,403,000 31 Mar 2021
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.22%
54,779
$11,254,000 31 Mar 2021
13F
SCOUT INVESTMENTS, INC.
13F
Company
0.21%
52,860
$10,860,000 31 Mar 2021
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.2%
50,476
$10,370,000 31 Mar 2021
13F

Institutional Holders of ICU MEDICAL INC/DE - Common Stock (ICUI) as of Q2 2021

As of 30 Jun 2021, ICU MEDICAL INC/DE - Common Stock (ICUI) was held by 266 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,303,486 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, BlackRock Inc., NUANCE INVESTMENTS, LLC, JPMORGAN CHASE & CO, Findlay Park Partners LLP, STATE STREET CORP, VICTORY CAPITAL MANAGEMENT INC, and ATLANTA CAPITAL MANAGEMENT CO L L C. This page lists 267 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
277
Q2 2021 holders
266
Holder diff
-11
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 Value $ Q2 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.